SCHEMBL4044632

SCHEMBL4044632

O=c1cc(O)ccn1C1CCCCO1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
CYP4F2 P78329 2/20 0.41
CYP4A11 Q02928 2/20 0.41
ALDH1A1 P00352 3/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 2/20 0.38
ESR1 P03372 1/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ACVRL1 P37023 1/20 0.36
ACVR1 Q04771 1/20 0.36
CYP2C19 P33261 1/20 0.34
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
RXRG P48443 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
HPGD P15428 1/20 0.33
HDAC1 Q13547 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9099722 0.95 KMT2A (0.48) KMT2AMEN1CYP4F2CYP4A11ALDH1A1
SCHEMBL4056563 0.76 POLB (0.43) KMT2AMEN1ALDH1A1POLBESR1
SCHEMBL116553 0.73 OPRM1 (0.39) LMNAPOLBMAOAMAOBOPRM1
SCHEMBL158414 0.73 CYP4F2 (0.52) KMT2AMEN1CYP4F2CYP4A11ALDH1A1
SCHEMBL28450968 0.71 KMT2A (0.38) KMT2AMEN1CYP4F2CYP4A11ALDH1A1
SCHEMBL15132784 0.71 KMT2A (0.48) KMT2AMEN1ALDH1A1LMNAPOLB
SCHEMBL4047527 0.70 MCHR1 (0.49)
SCHEMBL9838267 0.69 KMT2A (0.49) KMT2AMEN1ALDH1A1LMNAPOLB
SCHEMBL9098986 0.69 ALDH1A1 (0.43) KMT2AMEN1CYP4F2CYP4A11ALDH1A1
SCHEMBL9100183 0.69 KMT2A (0.46) KMT2AMEN1ALDH1A1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009103478-A1 PYRIDONE AND PYRIDAZINONE DERIVATIVES AS MCH ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-08-27 WO disclosed